New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that ultrasound-detected salivary gland abnormalities in primary Sjögren’s become more severe over time and that the slow-to-progress disease likely starts long before it is first detected.
Study finds potential for antidiabetic drugs to modify osteoarthritis risk
Whether antidiabetic medications could potentially be used as disease-modifying osteoarthritis drugs or DMOADs for the therapeutic management of osteoarthritis.
August 21, 2024